You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators
|
|---|---|
| Published in |
BMC Neurology, December 2009
|
| DOI | 10.1186/1471-2377-9-62 |
| Pubmed ID | |
| Authors |
Samuel Frank |
| Abstract |
Tetrabenazine (TBZ) selectively depletes central monoamines by reversibly binding to the type-2 vesicular monoamine transporter. A previous double blind study in Huntington disease (HD) demonstrated that TBZ effectively suppressed chorea, with a favorable short-term safety profile (Neurology 2006;66:366-372). The objective of this study was to assess the long-term safety and effectiveness of TBZ for chorea in HD. |
Mendeley readers
The data shown below were compiled from readership statistics for 218 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 2% |
| United Kingdom | 1 | <1% |
| Chile | 1 | <1% |
| Russia | 1 | <1% |
| Unknown | 211 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 33 | 15% |
| Student > Bachelor | 32 | 15% |
| Student > Ph. D. Student | 30 | 14% |
| Researcher | 29 | 13% |
| Other | 14 | 6% |
| Other | 40 | 18% |
| Unknown | 40 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 54 | 25% |
| Psychology | 26 | 12% |
| Neuroscience | 19 | 9% |
| Agricultural and Biological Sciences | 16 | 7% |
| Biochemistry, Genetics and Molecular Biology | 14 | 6% |
| Other | 38 | 17% |
| Unknown | 51 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 May 2022.
All research outputs
#7,449,539
of 22,774,233 outputs
Outputs from BMC Neurology
#845
of 2,428 outputs
Outputs of similar age
#48,233
of 163,597 outputs
Outputs of similar age from BMC Neurology
#4
of 7 outputs
Altmetric has tracked 22,774,233 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,428 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.7. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 163,597 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.